{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:26:24Z","timestamp":1776713184219,"version":"3.51.2"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2503801"],"award-info":[{"award-number":["2022YFC2503801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Epilepsy is a prevalent paroxysmal disorder in the field of neurology. Among the six etiologies of epilepsy, metabolic causes are relatively uncommon in clinical practice. Metabolic disorders encompass amino acid metabolism disorders, organic acid metabolism disorders, and other related conditions. Seizures resulting from nucleic acid\/nucleotide metabolism disorders are even more infrequent. This review provides an overview of several studies on nucleic acid\/nucleotide metabolism disorders associated with epilepsy, including adenosine succinate lyase deficiency, Lesch-Nyhan syndrome, and aminoimidazole carboxamide ribonucleotide transformylase\/inosine monophosphate cyclohydrolase (ATIC) deficiency, among others. The potential pathogenesis, phenotypic features, diagnostic pathways, and therapeutic approaches of these diseases are discussed in this review. The goal is to help clinicians make an accurate diagnosis when encountering rare nucleic acid\/nucleotide metabolism disorders with multi-system symptoms and manifestations of epilepsy.<\/jats:p>","DOI":"10.1186\/s42494-025-00201-x","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T23:16:20Z","timestamp":1743462980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The diagnosis and treatment of disorders of nucleic acid\/nucleotide metabolism associated with epilepsy"],"prefix":"10.1186","volume":"7","author":[{"given":"Yuqing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","unstructured":"Watts RWE. Disorders of purine and pyrimidine metabolism. In: Oxford Textbook of Medicine. Oxford University Press; 2010. https:\/\/doi.org\/10.1093\/med\/9780199204854.003.1204. Accessed 6 Dec 2024.","DOI":"10.1093\/med\/9780199204854.003.1204"},{"issue":"4","key":"201_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ymgme.2008.04.013","volume":"94","author":"A Jurecka","year":"2008","unstructured":"Jurecka A, Zikanova M, Tylki-Szymanska A, Krijt J, Bogdanska A, Gradowska W, et al. Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency. Mol Genet Metab. 2008;94(4):435\u201342.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"201_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ymgme.2019.06.001","volume":"127","author":"A Madeo","year":"2019","unstructured":"Madeo A, Di Rocco M, Brassier A, Bahi-Buisson N, De Lonlay P, Ceballos-Picot I. Clinical, biochemical and genetic characteristics of a cohort of 101 French and Italian patients with HPRT deficiency. Mol Genet Metab. 2019;127(2):147\u201357.","journal-title":"Mol Genet Metab"},{"issue":"22","key":"201_CR4","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/hmg\/ddh303","volume":"13","author":"AB van Kuilenburg","year":"2004","unstructured":"van Kuilenburg AB, Meinsma R, Beke E, Assmann B, Ribes A, Lorente I, et al. beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Hum Mol Genet. 2004;13(22):2793\u2013801.","journal-title":"Hum Mol Genet"},{"issue":"8411","key":"201_CR5","first-page":"1058","volume":"2","author":"J Jaeken","year":"1984","unstructured":"Jaeken J, Van den Berghe G. An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet (London, England). 1984;2(8411):1058\u201361.","journal-title":"Lancet (London, England)"},{"key":"201_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-4615-5381-6_36","volume":"431","author":"TW Stone","year":"1998","unstructured":"Stone TW, Roberts LA, Morris BJ, Jones PA, Ogilvy HA, Behan WM, et al. Succinylpurines induce neuronal damage in the rat brain. Adv Exp Med Biol. 1998;431:185\u20139.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"201_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/BF02435992","volume":"15","author":"J Jaeken","year":"1992","unstructured":"Jaeken J, Van den Bergh F, Vincent MF, Casaer P, Van den Berghe G. Adenylosuccinase deficiency: a newly recognized variant. J Inherit Metab Dis. 1992;15(3):416\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"201_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpeds.2006.09.027","volume":"150","author":"K Mouchegh","year":"2007","unstructured":"Mouchegh K, Zik\u00e1nov\u00e1 M, Hoffmann GF, Kretzschmar B, K\u00fchn T, Mildenberger E, et al. Lethal fetal and early neonatal presentation of adenylosuccinate lyase deficiency: observation of 6 patients in 4 families. J Pediatr. 2007;150(1):57-61.e2.","journal-title":"J Pediatr"},{"issue":"2","key":"201_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF00445919","volume":"148","author":"J Jaeken","year":"1988","unstructured":"Jaeken J, Wadman SK, Duran M, van Sprang FJ, Beemer FA, Holl RA, et al. Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr. 1988;148(2):126\u201331.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"201_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1023\/A:1005323512982","volume":"20","author":"PD Maaswinkel-Mooij","year":"1997","unstructured":"Maaswinkel-Mooij PD, Laan LA, Onkenhout W, Brouwer OF, Jaeken J, Poorthuis BJ. Adenylosuccinase deficiency presenting with epilepsy in early infancy. J Inherit Metab Dis. 1997;20(4):606\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"201_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/ejpn.1999.0172","volume":"3","author":"M K\u00f6hler","year":"1999","unstructured":"K\u00f6hler M, Assmann B, Br\u00e4utigam C, Storm W, Marie S, Vincent MF, et al. Adenylosuccinase deficiency: possibly underdiagnosed encephalopathy with variable clinical features. Eur J Paediatr Neurol. 1999;3(1):3\u20136.","journal-title":"Eur J Paediatr Neurol"},{"key":"201_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/978-1-4615-2584-4_79","volume":"370","author":"J Krijt","year":"1994","unstructured":"Krijt J, Sebesta I, Svehlakova A, Zumrova A, Zeman J. Adenylosuccinate lyase deficiency in a Czech girl and two siblings. Adv Exp Med Biol. 1994;370:367\u201370.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"201_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0887-8994(97)89979-1","volume":"16","author":"D Valik","year":"1997","unstructured":"Valik D, Miner PT, Jones JD. First U.S. case of adenylosuccinate lyase deficiency with severe hypotonia. Pediatr Neurol. 1997;16(3):252\u20135.","journal-title":"Pediatr Neurol."},{"issue":"1","key":"201_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ejhg.2008.174","volume":"17","author":"C Gitiaux","year":"2009","unstructured":"Gitiaux C, Ceballos-Picot I, Marie S, Valayannopoulos V, Rio M, Verrieres S, et al. Misleading behavioural phenotype with adenylosuccinate lyase deficiency. European journal of human genetics\u202f: EJHG. 2009;17(1):133\u20136.","journal-title":"European journal of human genetics : EJHG"},{"issue":"1","key":"201_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0003-2697(86)90158-2","volume":"156","author":"PK Laikind","year":"1986","unstructured":"Laikind PK, Seegmiller JE, Gruber HE. Detection of 5\u2019-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity. Anal Biochem. 1986;156(1):81\u201390.","journal-title":"Anal Biochem"},{"issue":"6","key":"201_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1373\/clinchem.2005.058842","volume":"52","author":"S Hartmann","year":"2006","unstructured":"Hartmann S, Okun JG, Schmidt C, Langhans CD, Garbade SF, Burgard P, et al. Comprehensive detection of disorders of purine and pyrimidine metabolism by HPLC with electrospray ionization tandem mass spectrometry. Clin Chem. 2006;52(6):1127\u201337.","journal-title":"Clin Chem"},{"issue":"11","key":"201_CR17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/dmcn.12244","volume":"55","author":"MA van Werkhoven","year":"2013","unstructured":"van Werkhoven MA, Duley JA, McGown I, Munce T, Freeman JL, Pitt JJ. Early diagnosis of adenylosuccinate lyase deficiency using a high-throughput screening method and a trial of oral S-adenosyl-l-methionine as a treatment method. Dev Med Child Neurol. 2013;55(11):1060\u20134.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"201_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.braindev.2007.03.005","volume":"29","author":"E Jurkiewicz","year":"2007","unstructured":"Jurkiewicz E, Mierzewska H, Ku\u015bmierska K. Adenylosuccinate lyase deficiency: the first identified polish patient. Brain Develop. 2007;29(9):600\u20132.","journal-title":"Brain Develop"},{"issue":"1","key":"201_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13052-017-0383-7","volume":"43","author":"M Macchiaiolo","year":"2017","unstructured":"Macchiaiolo M, Barresi S, Cecconi F, Zanni G, Niceta M, Bellacchio E, et al. A mild form of adenylosuccinate lyase deficiency in absence of typical brain MRI features diagnosed by whole exome sequencing. Ital J Pediatr. 2017;43(1):65.","journal-title":"Ital J Pediatr"},{"issue":"2","key":"201_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.radcr.2018.11.001","volume":"14","author":"S Kayfan","year":"2019","unstructured":"Kayfan S, Yazdani RM, Castillo S, Wong K, Miller JH, Pfeifer CM. MRI findings of hypomyelination in adenylosuccinate lyase deficiency. Radiol Case Rep. 2019;14(2):255\u20139.","journal-title":"Radiol Case Rep"},{"issue":"1","key":"201_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13023-021-01731-6","volume":"16","author":"G Mastrogiorgio","year":"2021","unstructured":"Mastrogiorgio G, Macchiaiolo M, Buonuomo PS, Bellacchio E, Bordi M, Vecchio D, et al. Clinical and molecular characterization of patients with adenylosuccinate lyase deficiency. Orphanet J Rare Dis. 2021;16(1):112.","journal-title":"Orphanet J Rare Dis"},{"key":"201_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4615-5381-6_34","volume":"431","author":"C Salerno","year":"1998","unstructured":"Salerno C, Celli M, Finocchiaro R, D\u2019Eufemia P, Iannetti P, Crif\u00f2 C, et al. Effect of D-ribose administration to a patient with inherited deficit of adenylosuccinase. Adv Exp Med Biol. 1998;431:177\u201380.","journal-title":"Adv Exp Med Biol"},{"key":"201_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/0-306-46843-3_14","volume":"486","author":"C Salerno","year":"2000","unstructured":"Salerno C, Crifo C, Curatolo P, Ciardo F. Effect of uridine administration to a patient with adenylosuccinate lyase deficiency. Adv Exp Med Biol. 2000;486:75\u20138.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"201_CR24","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.1542\/peds.105.4.e46","volume":"105","author":"F Lefevre","year":"2000","unstructured":"Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000;105(4):E46.","journal-title":"Pediatrics"},{"issue":"1","key":"201_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-011-1503-9","volume":"171","author":"A Jurecka","year":"2012","unstructured":"Jurecka A, Jurkiewicz E, Tylki-Szymanska A. Magnetic resonance imaging of the brain in adenylosuccinate lyase deficiency: a report of seven cases and a review of the literature. Eur J Pediatr. 2012;171(1):131\u20138.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"201_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tins.2008.02.009","volume":"31","author":"SA Masino","year":"2008","unstructured":"Masino SA, Geiger JD. Are purines mediators of the anticonvulsant\/neuroprotective effects of ketogenic diets? Trends Neurosci. 2008;31(6):273\u20138.","journal-title":"Trends Neurosci"},{"issue":"2","key":"201_CR27","first-page":"393","volume":"6","author":"PI Patel","year":"1986","unstructured":"Patel PI, Framson PE, Caskey CT, Chinault AC. Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol. 1986;6(2):393\u2013403.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"201_CR28","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0021-9258(19)56968-X","volume":"243","author":"FM Rosenbloom","year":"1968","unstructured":"Rosenbloom FM, Henderson JF, Caldwell IC, Kelley WN, Seegmiller JE. Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem. 1968;243(6):1166\u201373.","journal-title":"J Biol Chem"},{"issue":"1","key":"201_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymgme.2014.11.001","volume":"114","author":"R Fu","year":"2015","unstructured":"Fu R, Sutcliffe D, Zhao H, Huang X, Schretlen DJ, Benkovic S, et al. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways. Mol Genet Metab. 2015;114(1):55\u201361.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"201_CR30","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/art.24617","volume":"60","author":"HK Ea","year":"2009","unstructured":"Ea HK, Bardin T, Jinnah HA, Aral B, Liot\u00e9 F, Ceballos-Picot I. Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. Arthritis Rheum. 2009;60(7):2201\u20134.","journal-title":"Arthritis Rheum"},{"issue":"Pt 5","key":"201_CR31","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/brain\/awl056","volume":"129","author":"HA Jinnah","year":"2006","unstructured":"Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain J Neurol. 2006;129(Pt 5):1201\u201317.","journal-title":"Brain J Neurol"},{"key":"201_CR32","unstructured":"Jinnah HA. HPRT1 Disorders. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews(\u00ae)[Internet]. Seattle (WA): University of Washington; 2000. p. 1993\u20132025."},{"key":"201_CR33","first-page":"23","volume":"35","author":"A Christy","year":"2017","unstructured":"Christy A, Nyhan W, Wilson J. Severe Respiratory Acidosis in Status Epilepticus as a Possible Etiology of Sudden Death in Lesch-Nyhan Disease: A Case Report and Review of the Literature. JIMD Rep. 2017;35:23\u20138.","journal-title":"JIMD Rep"},{"issue":"Pt 3","key":"201_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1042\/bj20031035","volume":"377","author":"RJ Torres","year":"2004","unstructured":"Torres RJ, Deantonio I, Prior C, Puig JG. Adenosine transport in peripheral blood lymphocytes from Lesch-Nyhan patients. Biochem J. 2004;377(Pt 3):733\u20139.","journal-title":"Biochem J"},{"issue":"11","key":"201_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1365-2362.2007.01869.x","volume":"37","author":"C Prior","year":"2007","unstructured":"Prior C, Torres RJ, Puig JG. Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients. Eur J Clin Invest. 2007;37(11):905\u201311.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"201_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-006-9037-y","volume":"22","author":"CS Bavaresco","year":"2007","unstructured":"Bavaresco CS, Chiarani F, Wannmacher CM, Netto CA, Wyse AT. Intrastriatal hypoxanthine reduces Na(+), K (+)-ATPase activity and induces oxidative stress in the rats. Metab Brain Dis. 2007;22(1):1\u201311.","journal-title":"Metab Brain Dis"},{"key":"201_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1172-2-48","volume":"2","author":"RJ Torres","year":"2007","unstructured":"Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis. 2007;2:48.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"201_CR38","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1001\/archinte.1985.00360080174026","volume":"145","author":"RW Rundles","year":"1985","unstructured":"Rundles RW. The development of allopurinol. Arch Intern Med. 1985;145(8):1492\u2013503.","journal-title":"Arch Intern Med"},{"issue":"9","key":"201_CR39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.metabol.2007.04.013","volume":"56","author":"RJ Torres","year":"2007","unstructured":"Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 2007;56(9):1179\u201386.","journal-title":"Metabolism."},{"issue":"2","key":"201_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0145445500242003","volume":"24","author":"L Olson","year":"2000","unstructured":"Olson L, Houlihan D. A review of behavioral treatments used for Lesch-Nyhan syndrome. Behav Modif. 2000;24(2):202\u201322.","journal-title":"Behav Modif"},{"key":"201_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13023-014-0208-3","volume":"9","author":"M Pozzi","year":"2014","unstructured":"Pozzi M, Piccinini L, Gallo M, Motta F, Radice S, Clementi E. Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen. Orphanet J Rare Dis. 2014;9:208.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"201_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0887-8994(98)00166-0","volume":"20","author":"J McManaman","year":"1999","unstructured":"McManaman J, Tam DA. Gabapentin for self-injurious behavior in Lesch-Nyhan syndrome. Pediatr Neurol. 1999;20(5):381\u20132.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"201_CR43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000502568","volume":"11","author":"K Momosaki","year":"2019","unstructured":"Momosaki K, Kido J, Matsumoto S, Taniguchi A, Akiyama T, Sawada T, et al. The Effect of S-Adenosylmethionine Treatment on Neurobehavioral Phenotypes in Lesch-Nyhan Disease: A Case Report. Case Rep Neurol. 2019;11(3):256\u201364.","journal-title":"Case Rep Neurol"},{"issue":"1","key":"201_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10143-023-01950-4","volume":"46","author":"H Deng","year":"2023","unstructured":"Deng H, Xiong BT, Wu Y, Wang W. Deep brain stimulation in Lesch-Nyhan syndrome: a systematic review. Neurosurg Rev. 2023;46(1):40.","journal-title":"Neurosurg Rev"},{"issue":"1","key":"201_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1020661514514","volume":"14","author":"BE Wojcik","year":"1999","unstructured":"Wojcik BE, Jinnah HA, Muller-Sieburg CE, Friedmann T. Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT). Metab Brain Dis. 1999;14(1):57\u201365.","journal-title":"Metab Brain Dis"},{"issue":"3","key":"201_CR46","first-page":"175","volume":"68","author":"FJ Cusumano","year":"2001","unstructured":"Cusumano FJ, Penna KJ, Panossian G. Prevention of self-mutilation in patients with Lesch-Nyhan syndrome: review of literature. ASDC J Dent Child. 2001;68(3):175\u20138.","journal-title":"ASDC J Dent Child"},{"issue":"4","key":"201_CR47","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1074\/jbc.271.4.2225","volume":"271","author":"EA Rayl","year":"1996","unstructured":"Rayl EA, Moroson BA, Beardsley GP. The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase\/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping. J Biol Chem. 1996;271(4):2225\u201333.","journal-title":"J Biol Chem."},{"issue":"(Pt 1)(Pt 1)","key":"201_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/bj2810267","volume":"281","author":"MF Vincent","year":"1992","unstructured":"Vincent MF, Bontemps F, Van den Berghe G. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes. Biochem J. 1992;281((Pt 1)(Pt 1)):267\u201372.","journal-title":"Biochem J."},{"issue":"7","key":"201_CR49","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1096\/fasebj.9.7.7737463","volume":"9","author":"N Henin","year":"1995","unstructured":"Henin N, Vincent MF, Gruber HE, Van den Berghe G. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 1995;9(7):541\u20136.","journal-title":"FASEB J"},{"issue":"2","key":"201_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","volume":"229","author":"JM Corton","year":"1995","unstructured":"Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem. 1995;229(2):558\u201365.","journal-title":"Eur J Biochem."},{"issue":"4","key":"201_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0306-4522(02)00836-9","volume":"117","author":"M Garcia-Gil","year":"2003","unstructured":"Garcia-Gil M, Pesi R, Perna S, Allegrini S, Giannecchini M, Camici M, et al. 5\u2019-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience. 2003;117(4):811\u201320.","journal-title":"Neuroscience"},{"issue":"9\u201311","key":"201_CR52","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/15257770600890905","volume":"25","author":"M Garcia-Gil","year":"2006","unstructured":"Garcia-Gil M, Bertini F, Pesi R, Voccoli V, Tozzi MG, Camici M. 5 \u2019-Amino-4-imidazolecarboxamide riboside induces apoptosis in human neuroblastoma cells via the mitochondrial pathway. Nucleosides Nucleotides Nucleic Acids. 2006;25(9\u201311):1265\u201370.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"6","key":"201_CR53","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/jimd.12274","volume":"43","author":"F Ramond","year":"2020","unstructured":"Ramond F, Rio M, Heron B, Imbard A, Marie S, Billiemaz K, et al. AICA-ribosiduria due to ATIC deficiency: Delineation of the phenotype with three novel cases, and long-term update on the first case. J Inherit Metab Dis. 2020;43(6):1254\u201364.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"201_CR54","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1086\/421475","volume":"74","author":"S Marie","year":"2004","unstructured":"Marie S, Heron B, Bitoun P, Timmerman T, Van Den Berghe G, Vincent MF. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am J Hum Genet. 2004;74(6):1276\u201381.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"201_CR55","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/hmg\/ddr591","volume":"21","author":"V Baresova","year":"2012","unstructured":"Baresova V, Skopova V, Sikora J, Patterson D, Sovova J, Zikanova M, et al. Mutations of ATIC and ADSL affect purinosome assembly in cultured skin fibroblasts from patients with AICA-ribosiduria and ADSL deficiency. Hum Mol Genet. 2012;21(7):1534\u201343.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"201_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cell.2013.07.005","volume":"154","author":"N Akizu","year":"2013","unstructured":"Akizu N, Cantagrel V, Schroth J, Cai N, Vaux K, McCloskey D, et al. AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder. Cell. 2013;154(3):505\u201317.","journal-title":"Cell"},{"issue":"6170","key":"201_CR57","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1126\/science.1247363","volume":"343","author":"G Novarino","year":"2014","unstructured":"Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD, et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science (New York, NY). 2014;343(6170):506\u201311.","journal-title":"Science (New York, NY)"},{"issue":"12","key":"201_CR58","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.21037\/qims.2019.08.12","volume":"9","author":"E Scola","year":"2019","unstructured":"Scola E, Ganau M, Robinson R, Cleary M, De Cocker LJL, Mankad K, et al. Neuroradiological findings in three cases of pontocerebellar hypoplasia type 9 due to AMPD2 mutation: typical MRI appearances and pearls for differential diagnosis. Quant Imaging Med Surg. 2019;9(12):1966\u201372.","journal-title":"Quant Imaging Med Surg"},{"issue":"2","key":"201_CR59","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1212\/NXG.0000000000000014","volume":"1","author":"AP Marsh","year":"2015","unstructured":"Marsh AP, Lukic V, Pope K, Bromhead C, Tankard R, Ryan MM, et al. Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss. Neurol Genet. 2015;1(2):e16.","journal-title":"Neurol Genet"},{"issue":"5","key":"201_CR60","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41431-018-0098-2","volume":"26","author":"F Kortum","year":"2018","unstructured":"Kortum F, Jamra RA, Alawi M, Berry SA, Borck G, Helbig KL, et al. Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9. Eur J Hum Genet. 2018;26(5):695\u2013708.","journal-title":"Eur J Hum Genet."},{"issue":"4","key":"201_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Pt A","key":"201_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","volume":"298","author":"CA Peixoto","year":"2017","unstructured":"Peixoto CA, Oliveira WH, Araujo S, Nunes AKS. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol. 2017;298(Pt A):31\u201341.","journal-title":"Exp Neurol"},{"key":"201_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.578830","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Xu Y, Hu F. AMPK in the Ventromedial Nucleus of the Hypothalamus: A Key Regulator for Thermogenesis. Front Endocrinol (Lausanne). 2020;11: 578830.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"201_CR64","doi-asserted-by":"crossref","unstructured":"Segatto M, Rosso P, Fioramonti M, Fracassi A, Marangoni M, Taglietti V, et al. AMPK in the central nervous system: physiological roles and pathological implications.\u00a0Res Rep Biol. 2016;7:1\u201313.","DOI":"10.2147\/RRB.S90858"},{"key":"201_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.672182","volume":"12","author":"M Garcia-Gil","year":"2021","unstructured":"Garcia-Gil M, Camici M, Allegrini S, Pesi R, Tozzi MG. Metabolic Aspects of Adenosine Functions in the Brain. Front Pharmacol. 2021;12: 672182.","journal-title":"Front Pharmacol"},{"issue":"4","key":"201_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ajhg.2020.02.015","volume":"106","author":"TY Tan","year":"2020","unstructured":"Tan TY, Sedm\u00edk J, Fitzgerald MP, Halevy RS, Keegan LP, Helbig I, et al. Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures. Am J Hum Genet. 2020;106(4):467\u201383.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"201_CR67","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1006\/geno.1997.4655","volume":"41","author":"L Mittaz","year":"1997","unstructured":"Mittaz L, Scott HS, Rossier C, Seeburg PH, Higuchi M, Antonarakis SE. Cloning of a human RNA editing deaminase (ADARB1) of glutamate receptors that maps to chromosome 21q22.3. Genomics. 1997;41(2):210\u20137.","journal-title":"Genomics."},{"issue":"1","key":"201_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ng.3731","volume":"49","author":"H Terajima","year":"2017","unstructured":"Terajima H, Yoshitane H, Ozaki H, Suzuki Y, Shimba S, Kuroda S, et al. ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm. Nat Genet. 2017;49(1):146\u201351.","journal-title":"Nat Genet"},{"issue":"5007","key":"201_CR69","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1709304","volume":"252","author":"M Hollmann","year":"1991","unstructured":"Hollmann M, Hartley M, Heinemann S. Ca2+ permeability of KA-AMPA\u2013gated glutamate receptor channels depends on subunit composition. Science (New York, NY). 1991;252(5007):851\u20133.","journal-title":"Science (New York, NY)"},{"issue":"7","key":"201_CR70","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jmedgenet-2020-107048","volume":"58","author":"R Maroofian","year":"2021","unstructured":"Maroofian R, Sedmik J, Mazaheri N, Scala M, Zaki MS, Keegan LP, et al. Biallelic variants in ADARB1, encoding a dsRNA-specific adenosine deaminase, cause a severe developmental and epileptic encephalopathy. J Med Genet. 2021;58(7):495\u2013504.","journal-title":"J Med Genet"},{"key":"201_CR71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.seizure.2019.12.024","volume":"75","author":"FM Chang","year":"2020","unstructured":"Chang FM, Fan PC, Weng WC, Chang CH, Lee WT. The efficacy of perampanel in young children with drug-resistant epilepsy. Seizure. 2020;75:82\u20136.","journal-title":"Seizure"},{"issue":"2\u20133","key":"201_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(79)90410-8","volume":"97","author":"SL Holmes","year":"1979","unstructured":"Holmes SL, Turner BM, Hirschhorn K. Human inosine triphosphatase: catalytic properties and population studies. Clin Chim Acta. 1979;97(2\u20133):143\u201353.","journal-title":"Clin Chim Acta"},{"issue":"4\u20135","key":"201_CR73","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","volume":"111","author":"S Sumi","year":"2002","unstructured":"Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet. 2002;111(4\u20135):360\u20137.","journal-title":"Hum Genet"},{"issue":"4","key":"201_CR74","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ana.24496","volume":"78","author":"SH Kevelam","year":"2015","unstructured":"Kevelam SH, Bierau J, Salvarinova R, Agrawal S, Honzik T, Visser D, et al. Recessive ITPA mutations cause an early infantile encephalopathy. Ann Neurol. 2015;78(4):649\u201358.","journal-title":"Ann Neurol"},{"issue":"3","key":"201_CR75","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/humu.24326","volume":"43","author":"M Scala","year":"2022","unstructured":"Scala M, Wortmann SB, Kaya N, Stellingwerff MD, Pistorio A, Glamuzina E, et al. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022;43(3):403\u201319.","journal-title":"Hum Mutat"},{"issue":"2","key":"201_CR76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/clpt.2008.154","volume":"85","author":"G Stocco","year":"2009","unstructured":"Stocco G, Cheok MH, Crews KR, Dervieux T, French D, Pei D, et al. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther. 2009;85(2):164\u201372.","journal-title":"Clin Pharmacol Ther"},{"key":"201_CR77","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12967-015-0682-y","volume":"13","author":"D Pineda-Tenor","year":"2015","unstructured":"Pineda-Tenor D, Garc\u00eda-\u00c1lvarez M, Jim\u00e9nez-Sousa MA, V\u00e1zquez-Mor\u00f3n S, Resino S. Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis. J Transl Med. 2015;13:320.","journal-title":"J Transl Med"},{"issue":"7287","key":"201_CR78","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature08825","volume":"464","author":"J Fellay","year":"2010","unstructured":"Fellay J, Thompson AJ, Ge D, Gumbs CE, Urban TJ, Shianna KV, et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature. 2010;464(7287):405\u20138.","journal-title":"Nature"},{"issue":"3","key":"201_CR79","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/geno.1998.5379","volume":"51","author":"X Wei","year":"1998","unstructured":"Wei X, Elizondo G, Sapone A, McLeod HL, Raunio H, Fernandez-Salguero P, et al. Characterization of the human dihydropyrimidine dehydrogenase gene. Genomics. 1998;51(3):391\u2013400.","journal-title":"Genomics"},{"issue":"1","key":"201_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/PL00008711","volume":"104","author":"AB Van Kuilenburg","year":"1999","unstructured":"Van Kuilenburg AB, Vreken P, Abeling NG, Bakker HD, Meinsma R, Van Lenthe H, et al. Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet. 1999;104(1):1\u20139.","journal-title":"Hum Genet"},{"issue":"1","key":"201_CR81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0014-5793(92)80109-T","volume":"299","author":"NJ Mabjeesh","year":"1992","unstructured":"Mabjeesh NJ, Frese M, Rauen T, Jeserich G, Kanner BI. Neuronal and glial gamma-aminobutyric acid+ transporters are distinct proteins. FEBS Lett. 1992;299(1):99\u2013102.","journal-title":"FEBS Lett"},{"key":"201_CR82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejca.2020.01.019","volume":"129","author":"A Boil\u00e8ve","year":"2020","unstructured":"Boil\u00e8ve A, Thomas L, Lillo-Le Lou\u00ebt A, Gaboriau L, Chouchana L, Ducreux M, et al. 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey. Eur J Cancer. 2020;129:32\u201340.","journal-title":"Eur J Cancer."},{"issue":"4","key":"201_CR83","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1023\/B:BOLI.0000037350.24142.d5","volume":"27","author":"GM Enns","year":"2004","unstructured":"Enns GM, Barkovich AJ, van Kuilenburg AB, Manning M, Sanger T, Witt DR, et al. Head imaging abnormalities in dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(4):513\u201322.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"201_CR84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-510X(87)90079-7","volume":"78","author":"JP Braakhekke","year":"1987","unstructured":"Braakhekke JP, Renier WO, Gabre\u00ebls FJ, De Abreu RA, Bakkeren JA, Sengers RC. Dihydropyrimidine dehydrogenase deficiency. Neurological aspects. J Neurol Sci. 1987;78(1):71\u20137.","journal-title":"J Neurol Sci"},{"key":"201_CR85","first-page":"49","volume":"37","author":"M Fleger","year":"2017","unstructured":"Fleger M, Willomitzer J, Meinsma R, Alders M, Meijer J, Hennekam RCM, et al. Dihydropyrimidine Dehydrogenase Deficiency: Metabolic Disease or Biochemical Phenotype? JIMD Rep. 2017;37:49\u201354.","journal-title":"JIMD Rep"},{"issue":"1","key":"201_CR86","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF01799339","volume":"13","author":"M Brockstedt","year":"1990","unstructured":"Brockstedt M, Jakobs C, Smit LM, van Gennip AH, Berger R. A new case of dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis. 1990;13(1):121\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"201_CR87","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1023\/A:1005399131620","volume":"20","author":"I Holopainen","year":"1997","unstructured":"Holopainen I, Pulkki K, Heinonen OJ, N\u00e4nt\u00f6-Salonen K, Haataja L, Greter J, et al. Partial epilepsy in a girl with a symptom-free sister: first two Finnish patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis. 1997;20(5):719\u201320.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"201_CR88","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1476-5381.1996.tb15710.x","volume":"119","author":"M Pfeiffer","year":"1996","unstructured":"Pfeiffer M, Draguhn A, Meierkord H, Heinemann U. Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br J Pharmacol. 1996;119(3):569\u201377.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"201_CR89","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1086\/302022","volume":"63","author":"N Hamajima","year":"1998","unstructured":"Hamajima N, Kouwaki M, Vreken P, Matsuda K, Sumi S, Imaeda M, et al. Dihydropyrimidinase deficiency: structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene. Am J Hum Genet. 1998;63(3):717\u201326.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"201_CR90","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0026-895X(24)23072-8","volume":"56","author":"V Schmieden","year":"1999","unstructured":"Schmieden V, Kuhse J, Betz H. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition. Mol Pharmacol. 1999;56(3):464\u201372.","journal-title":"Mol Pharmacol"},{"issue":"9","key":"201_CR91","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/oby.2008.337","volume":"16","author":"K Begriche","year":"2008","unstructured":"Begriche K, Massart J, Abbey-Toby A, Igoudjil A, Lett\u00e9ron P, Fromenty B. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency. Obesity (Silver Spring, Md). 2008;16(9):2053\u201367.","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"6","key":"201_CR92","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.peptides.2005.10.006","volume":"27","author":"SA Farr","year":"2006","unstructured":"Farr SA, Banks WA, Morley JE. Effects of leptin on memory processing. Peptides. 2006;27(6):1420\u20135.","journal-title":"Peptides"},{"issue":"5","key":"201_CR93","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/j.1471-4159.2008.05457.x","volume":"106","author":"AP Signore","year":"2008","unstructured":"Signore AP, Zhang F, Weng Z, Gao Y, Chen J. Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J Neurochem. 2008;106(5):1977\u201390.","journal-title":"J Neurochem"},{"issue":"1","key":"201_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/JCI34511","volume":"118","author":"S Diano","year":"2008","unstructured":"Diano S, Horvath TL. Anticonvulsant effects of leptin in epilepsy. J Clin Investig. 2008;118(1):26\u20138.","journal-title":"J Clin Investig"},{"issue":"7\u20138","key":"201_CR95","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbadis.2010.03.013","volume":"1802","author":"AB van Kuilenburg","year":"2010","unstructured":"van Kuilenburg AB, Dobritzsch D, Meijer J, Meinsma R, Benoist JF, Assmann B, et al. Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients. Biochim Biophys Acta. 2010;1802(7\u20138):639\u201348.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"201_CR96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ymgme.2017.10.003","volume":"122","author":"Y Nakajima","year":"2017","unstructured":"Nakajima Y, Meijer J, Dobritzsch D, Ito T, Zhang C, Wang X, et al. Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity. Mol Genet Metab. 2017;122(4):216\u201322.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"201_CR97","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/15257770802146445","volume":"27","author":"AB van Kuilenburg","year":"2008","unstructured":"van Kuilenburg AB, Stroomer AE, Bosch AM, Duran M. Beta-alanine and beta-aminoisobutyric acid levels in two siblings with dihydropyrimidinase deficiency. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):825\u20139.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"5","key":"201_CR98","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/BF01799851","volume":"19","author":"S Sumi","year":"1996","unstructured":"Sumi S, Kidouchi K, Hayashi K, Ohba S, Wada Y. Dihydropyrimidinuria without clinical symptoms. J Inherit Metab Dis. 1996;19(5):701\u20132.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"201_CR99","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2007.09.009","volume":"93","author":"J Yaplito-Lee","year":"2008","unstructured":"Yaplito-Lee J, Pitt J, Meijer J, Zoetekouw L, Meinsma R, van Kuilenburg AB. Beta-ureidopropionase deficiency presenting with congenital anomalies of the urogenital and colorectal systems. Mol Genet Metab. 2008;93(2):190\u20134.","journal-title":"Mol Genet Metab"},{"key":"201_CR100","first-page":"117","volume":"19","author":"JH Lee","year":"2015","unstructured":"Lee JH, van Kuilenburg AB, Abeling NG, Vasta V, Hahn SH. A Korean Case of beta-Ureidopropionase Deficiency Presenting with Intractable Seizure, Global Developmental Delay, and Microcephaly. JIMD Rep. 2015;19:117\u201321.","journal-title":"JIMD Rep"},{"issue":"3","key":"201_CR101","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ymgme.2022.01.102","volume":"136","author":"D Dobritzsch","year":"2022","unstructured":"Dobritzsch D, Meijer J, Meinsma R, Maurer D, Monavari AA, Gummesson A, et al. beta-Ureidopropionase deficiency due to novel and rare UPB1 mutations affecting pre-mRNA splicing and protein structural integrity and catalytic activity. Mol Genet Metab. 2022;136(3):177\u201385.","journal-title":"Mol Genet Metab"},{"key":"201_CR102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/0-306-46843-3_47","volume":"486","author":"AB van Kuilenburg","year":"2000","unstructured":"van Kuilenburg AB, van Lenthe H, Ratmann GG, Assmann B, Hoffmann GF, Brautigam C, et al. Confirmation of the enzyme defect in the first case of beta-ureidopropionase deficiency.\u00a0Beta-alanine deficiency. Adv Exp Med Biol. 2000;486:243\u20136.","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"201_CR103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-2006-923933","volume":"37","author":"B Assmann","year":"2006","unstructured":"Assmann B, G\u00f6hlich G, Baethmann M, Wevers RA, Van Gennip AH, Van Kuilenburg AB, et al. Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency. Neuropediatrics. 2006;37(1):20\u20135.","journal-title":"Neuropediatrics"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-025-00201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-025-00201-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-025-00201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T12:55:53Z","timestamp":1743512153000},"score":1,"resource":{"primary":{"URL":"https:\/\/aepi.biomedcentral.com\/articles\/10.1186\/s42494-025-00201-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1186\/s42494-025-00201-x","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"value":"2096-9384","type":"print"},{"value":"2524-4434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Yanchun Deng is a member of the Editorial Board for Acta Epileptologica, who was not involved in the journal\u2019s review of or decisions related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}